"10.1371_journal.pone.0142683","plos one","2015-11-16T00:00:00Z","Amalia Lamana; Mercedes López-Santalla; Raquel Castillo-González; Ana María Ortiz; Javier Martín; Rosario García-Vicuña; Isidoro González-Álvaro","Servicio de Reumatología, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Hospital Universitario La Princesa, Madrid, Spain; Departamento de Inmunología y Oncología, Centro Nacional de Biotecnología, CSIC, Madrid, Spain; Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain","Conceived and designed the experiments: AL MLS JM IGA. Performed the experiments: AL MLS RCG AO IGA. Analyzed the data: AL MLS RGV IGA. Wrote the paper: AL MLS JM RGV IGA.","During the last five years IGA has received unrestricted research grants from: Bristol-Myers Squibb, Roche and UCB. Measurement of IL-6 levels described in this article was supported by different research grants from Roche. The other research projects have no relation with the present study. RGV has been Technical Coordinator of “Estrategia de ERyME del SNS” [National Health Service Strategy for Rheumatic and Musculoskeletal Diseases]; funding for research, personnel or training, as well as paid consulting and delivering of presentations for Roche, BMS, MSD, Abbvie, UCB, Pfizer, Hospira; Member of the Pharmacy and Pharmacotherapeutic Commission of the HUP. The remaining authors have declared that no competing interests exist. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","11","Amalia Lamana","AL",7,FALSE,4,5,4,5,TRUE,TRUE,TRUE,1,"7",TRUE
